2024
DOI: 10.1186/s12645-024-00250-w
|View full text |Cite
|
Sign up to set email alerts
|

Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics

Yashaswi Dutta Gupta,
Yuri Mackeyev,
Sunil Krishnan
et al.

Abstract: Owing to unique facets, such as large surface area, tunable synthesis parameters, and ease of functionalization, mesoporous silica nanoparticles (MSNs) have transpired as a worthwhile platform for cancer theranostics over the last decade. The full potential of MSNs in cancer theranostics, however, is yet to be realized. While MSNs can be employed for targeted drug delivery and imaging, their effectiveness can frequently be hindered by factors, such as biological barriers, complex tumor microenvironment, target… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 239 publications
0
1
0
Order By: Relevance
“…With the expanding knowledge of cancer’s genetic and molecular foundations, nanotechnology can be harnessed to develop therapies tailored to individual patients. By customizing nanocarriers to match the distinct genetic makeup of a patient’s tumor, drug delivery and treatment efficacy can be optimized [ 218 , 222 ].…”
Section: Conclusion and Future Perspectivementioning
confidence: 99%
“…With the expanding knowledge of cancer’s genetic and molecular foundations, nanotechnology can be harnessed to develop therapies tailored to individual patients. By customizing nanocarriers to match the distinct genetic makeup of a patient’s tumor, drug delivery and treatment efficacy can be optimized [ 218 , 222 ].…”
Section: Conclusion and Future Perspectivementioning
confidence: 99%